Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Haydar Frangoul, MD
Vanderbilt University
Study Chair - Sandeep Soni, MD
Nationwide Childrens Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Childrens Hospital Los Angeles
Los Angeles, California, United States
- Nationwide Childrens Hospital
Columbus, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Vanderbilt Children'S Hospital
Nashville, Tennessee, United States
- Primary Children'S Hospital
Salt Lake City, Utah, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jan 2010
- Primary completion
- 31 Aug 2014
- Completion
- 31 Aug 2014
- Last update posted
- 1 Feb 2024
- Registered enrollment
- 18
- Registry id
- NCT01041508
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.